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Abstract
Background: Clara cells are the epithelial progenitor cell of the small airways, a location known
to be important in many lung disorders. Although migration of alveolar type II and bronchiolar
ciliated epithelial cells has been examined, the migratory response of Clara cells has received little
attention.
Methods: Using a modification of existing procedures for Clara cell isolation, we examined mouse
Clara cells and a mouse Clara-like cell line (C22) for adhesion to and migration toward matrix
substrate gradients, to establish the nature and integrin dependence of migration in Clara cells.
Results: We observed that Clara cells adhere preferentially to fibronectin (Fn) and type I collagen
(Col I) similar to previous reports. Migration of Clara cells can be directed by a fixed gradient of
matrix substrates (haptotaxis). Migration of the C22 cell line was similar to the Clara cells so
integrin dependence of migration was evaluated with this cell line. As determined by competition
with an RGD containing-peptide, migration of C22 cells toward Fn and laminin (Lm) 511 (formerly
laminin 10) was significantly RGD integrin dependent, but migration toward Col I was RGD integrin
independent, suggesting that Clara cells utilize different receptors for these different matrices.
Conclusion: Thus, Clara cells resemble alveolar type II and bronchiolar ciliated epithelial cells by
showing integrin mediated pro-migratory changes to extracellular matrix components that are
present in tissues after injury.
Background
Clara cells are epithelial cells on the luminal surface of air-
ways with a dome shaped cytoplasmic protrusion and no
cilia [1,2]. In addition to their secretory and xenobiotic
roles [3,4], Clara cells are the progenitor cell in small air-
ways [5]. After airway injury, Clara cells in stem cell niches
proliferate and migrate to replenish the injured terminally
differentiated epithelial cells [6]. In fact, after alveolar
injury, Clara cells can be seen in the alveolus (alveolar
bronchiolization), suggesting the response of the terminal
airway epithelium to alveolar injury exceeds the rate of
alveolar epithelial cell repair [7,8].
Epithelial repair requires a complex series of steps includ-
ing cell spreading and/or migration over the exposed
interstitial matrix and provisional matrix to form intact
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tight junctions (restitution), and replenishment of the ini-
tial cell density by proliferation and redistribution of dif-
ferentiated epithelial cells over the provisional matrix
(reconstitution). The response of epithelial cells to differ-
ent matrix components is of interest, as the provisional
matrix, which is generated after injury, contains new
epitopes that can influence epithelial cell commitment to
migration [9-15]. The addition of matrix molecules can
induce non-directional pro-migratory behaviour (chemo-
kinesis) in epithelial cells, but some epithelial cells will
migrate towards soluble gradients of substrate (chemo-
taxis) or affixed substrates which present a gradient of
adhesion sites (haptotaxis). Large airway ciliated cells and
alveolar type II cells both show haptotactic migration
toward the provisional matrix molecule fibronectin [9,12-
14], but the directed migration of Clara cells has only
been reported in mixed cell preparations where the per-
centage of Clara cells migrating was not defined [18].
At steady state, the basement membrane is composed of
two parallel sheets of laminin (Lm) and collagen (Col). In
the adult lung, the topmost layer is composed primarily of
Lm 332 (formerly laminin-5) and Lm 511 while the lower
layer is Col IV [16]. The underlying interstitial matrix con-
tains fibroblasts in a fibrillar Col (I and III) matrix. Fol-
lowing disruption of the epithelial cell layer and
basement membrane, a provisional matrix rich in
fibronectin (Fn) is formed. Provisional matrix molecules
contain multiple RGD (arginine-glycine-aspartic acid)
epitopes that are not present within the steady state matrix
[17]. This short peptide sequence provides sites for inter-
action of epithelial cell surface receptors (integrins) dur-
ing cell migration [11]. Migrating cells must alter surface
receptors for adhesion and traction across the provisional
matrix. The matrix-associated receptors in airway epithe-
lial cells during steady state are predominantly collagen
and laminin binding integrins (α2β1, α3β1 and α6β4),
that do not bind classic RGD epitopes [18]. After injury
bronchiolar epithelial cells express α5 and αv containing
integrins (fibronectin and vitronectin receptors) at the
wound edge [18]. Clara cells express α5, α6, αv, β1 and
β4, but do not express β3 integrin the typical partner for
αv [19].
The evaluation of Clara cell migration has been hampered
by their overall low abundance in human lungs and
restriction to the terminal airway. Although Clara cells are
much more abundant in rodents, especially in the termi-
nal airways [20], primary culture is complicated by rela-
tively impure yields and a rapid loss of phenotypic
characteristics in culture [19,21-25]. Until recently,
immortalized airway epithelial cell lines produced only
minimal amounts of Clara cell specific proteins and
lacked contact inhibition [26]. To overcome these difficul-
ties the C22 cell line was developed by isolating Clara cells
from the Imortomouse™ [27]. All cells from the Imorto-
mouse™ harbour a transgenic, temperature-sensitive,
MHC-driven, large-T antigen. Although these cells secrete
minimal Clara cell secretory protein (CC10), they make
CC10 mRNA and surfactant protein B but not C, which
defines them as Clara-like cells [27]. The C22 cells display
many of the characteristics of mature Clara cells, includ-
ing growth in monolayers and formation of tight junc-
tions [27].
The objectives of this study were to devise a reproducible
procedure for murine Clara cell isolation, to evaluate
Clara cell migration to several matrix substrates relevant
to wound repair, and to compare the C22 cell line to Clara
cells in adhesion and migration assays. After determina-
tion that C22 cells were similar to freshly isolated Clara
cells in assays of migration, we examined the role of RGD-
binding integrins on C22 cell migration.
Methods
Clara Cell Isolation
Clara cells were isolated from Swiss Webster mice
(Taconic Farms, Germantown, NY) using a protocol mod-
ified from Corti, et. al [28]. Mice were injected i.p. with
heparin (250 u/mouse) and killed by CO2 narcosis. After
transection of the dorsal vessels, the right ventricle was
canulated and the lungs were flushed with cold phosphate
buffered saline (PBS) until white (~10 ml) by directing the
catheter towards the main pulmonary artery. The trachea
was canulated with a 22 g catheter and 0.5 ml of 1% low
melting temperature agarose (Gibco, Grand Island, NY) in
PBS was instilled and the lungs were placed on ice for 2
min. Then 0.5 ml of 0.25% bovine pancreatic trypsin
(Sigma, St. Louis, MO, T-8003) in Hank's balanced salt
solution (without Ca++ or Mg++) was instilled, the trachea
was secured with a suture and the excised lungs were incu-
bated at 37°C for 10 min. Using a scalpel and scissors,
lung tissue was teased away from the large airways, diced
to approximately 1 mm3 pieces, and placed in DMEM
containing 250 μg/ml of DNAse I and antibiotic/antimy-
cotic (Cellgro, Herndon, VA) for 5 min minutes. The
resulting suspension was transferred to a 50 ml conical
tube, and fetal calf serum was added to achieve 10% of
final volume.
To remove the non-cellular portion, the suspension was
filtered through 100 and 40 μm filters sequentially and
the filtrate was sedimented by centrifugation at 200 g for
10 minutes. The cell pellet was resuspended in DMEM
with antibiotic/antimycotic and spun three times at 32 g
for 6 min at 10°C, each time discarding the supernatant
and resuspending the pellet in DMEM with antibiotic/
antimycotic.Respiratory Research 2008, 9:1 http://respiratory-research.com/content/9/1/1
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Cells were plated for 1 hr on 100 mm tissue culture dishes
pre-coated with 500 μg/ml mouse IgG (Sigma) to remove
fibroblasts. The non-adherent cells were collected and
aliquots were stained with nitroblue tetrazolium (NBT) as
described below to identify the Clara cells. The cells were
resuspended in DMEM containing 2% fetal calf serum
and antibiotic/antimycotic for all assays.
NBT Staining
To identify Clara cells, NBT staining was performed. Cells
were affixed to glass slides using a Shandon cytospin (5
min, 500 rpm). After air drying, cells were fixed in 10%
phosphate buffered formalin for 30 sec. Slides were incu-
bated in a fresh solution of 0.1% NBT (Sigma, N-6876)
and 0.1% NADPH (Sigma, N1630) in PBS with 25 mM
HEPES for 10 min at 37°C. Then slides were rinsed in dis-
tilled water and counterstained with methyl green. Only
Clara cells stain dark purple (see additional file 1 panel
A). The brief formalin fixation is necessary as some non-
Clara cells demonstrate weak purple staining.
Immunostaining for Cell Specific Markers
Commercial antibodies and concentrations were as fol-
lows: 1:1000 mouse anti-pan cytokeratin mixture (C2562,
Sigma, St. Louis), 1:5000 rabbit anti-pro-SP-C (Chemi-
con, Temecula, CA), 1:500 mouse anti-β-tubulin-IV (Bio-
genex, SanRamon, CA) and 1:200 mouse anti-vimentin
(Sigma, St. Louis, MO). Donkey anti-CC10 antibody was
a gift from Dr. G Singh (Pittsburgh VA Medical Center)
and used at 1:10,000. Mouse and rabbit IgG to control for
nonspecific binding were from Biocare Medical (Concord,
CA). FITC and TRITC-conjugated secondary antibodies
were used at a 1:200 concentration (Jackson Labs, Bar
Harbor, ME). Mounting media containing DAPI (Vector
Labs, Burlingame, CA) was used for immunofluorescent
staining.
Culture of C22 cells
C22 cells were developed as described [27]. They are a con-
ditionally immortalized cell line isolated from a C57Bl/10
× CBA hybrid strain mouse harbouring a temperature sen-
sitive, MHC driven large T antigen transgene (Immorto-
mouse, Charles River Labs). All cells have undergone less
than 30 passages. Cells were grown in permissive condi-
tions (33°C and proliferative media) prior to experiments
then transferred to non-permissive conditions (39°C and
differentiation media) 24 hrs prior to any experiments to
inactivate the large T-antigen. Differentiation media is as
defined [27] and proliferative media contains the same
supplements plus interferon γ (100 U/ml) to induce the
expression of the MHC driven large T-antigen.
Coating of Surfaces with Matrix Substrates
Bovine Fn (Sigma-Aldrich), mouse laminin 1 (Lm 111)
(Sigma-Aldrich), mouse Col IV (Chemicon), human pla-
cental laminin 10 (Lm 511) (Chemicon), and rat tail Col
I (BD Biosciences, Bedford, MA) were diluted to 50 mg/ml
in PBS. For Lm 332 the conditioned media of rat bladder
carcinoma cells (804 G, gift of Dr. G. Plopper, Rensselaer
Polytechnic Institute, NY) in DMEM (without serum) was
used undiluted. 804 G cells make a matrix that is predom-
inantly Lm 332 and the supernatant is enriched for the
processed form of Lm 332 [29,30]. Chamber slides were
coated with the matrix substrates by incubation of the
slides with matrix solution for 1 hr at room temperature.
Slides were washed 3 times with PBS and air-dried. The
undersurfaces of the 8 μm polycarbonate membranes
(Neuro Probe Inc, Gaithersburg, MD) used in haptotaxis
experiments were coated with matrix substrates by float-
ing the membrane on the matrix solutions for 1 hr at
room temperature.
Adhesion Assays
Clara cells were plated on uncoated glass or chamber
slides coated with matrix substrates. The cells were incu-
bated for 18 hrs in 5% CO2 at 37°C, then the slides were
gently washed with PBS three times to remove non-adher-
ent cells and mounted with a DAPI counterstain. Cells
were stained for CC10 to determine the identity of adher-
ent cells. The number of adherent Clara cells was counted
in five high power fields (hpf, 200×) per slide. Results rep-
resent the average number of cells per hpf from at least 3
independent isolations +/- SEM. For studies using C22
cells, procedures were similar except the cells were har-
vested using 0.05% trypsin/53 mM EDTA for 3 minutes
and incubation for adhesion was only 30 min.
Proliferation Assays
Clara cells were plated on uncoated glass or chamber
slides coated with matrix substrates. After 18 hrs at 37°C
in 5% CO2, unattached cells were removed by gentle
washing with PBS. The media was replaced with DMEM
containing 10% fetal calf serum and 10 μg/ml bromode-
oxyuridine (BrdU, Sigma-Aldrich) and cells were incu-
bated for an additional 24 hrs. Cells were fixed with 10%
phosphate buffered formalin for 10 min at room temper-
ature and permeablized with PBS containing 0.5% Triton
X-100. BrdU incorporation was evaluated by immunos-
taining using a 1:200 dilution of rat anti-BrdU antibody
(Accurate Chemical, Westbury, NY) followed by a 1:200
dilution of TRITC-conjugated anti-rat secondary anti-
body. Slides were mounted with aqueous mounting
media containing DAPI. The TRITC-positive and DAPI-
positive cells were counted in five hpfs per slide. Results
represent the average percentage of cells that underwent
proliferation during the time period of the assay (i.e. the
number of TRITC-positive cells divided by the number of
DAPI-positive cells) per hpf from at least 5 independent
experiments +/- SEM.Respiratory Research 2008, 9:1 http://respiratory-research.com/content/9/1/1
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Haptotaxis
Haptotaxis is directed migration towards an increasing
gradient of adhesion sites. Typically incubation of a
porous membrane with a saturating concentration of the
substrate that contains the necessary epitopes will create a
gradient that is greatest on the coated surface. Membranes
were coated as described then placed with coated surface
down in modified Boyden chambers (Neuroprobe, Gaith-
ersburg, MD). Clara cells or trypsinized C22 cells (2 × 106
cells in 50 μl) were placed in the upper well of modified
Boyden chambers. Clara cells require 2% serum for adhe-
sion [31], so serum was added to the upper well only
(serum was not added in migration experiments of C22
cells). Chambers were placed in an incubator at 37°C and
5% CO2 and cells were allowed to migrate for 8, 16 or 24
hrs. Cells were fixed and stained with Dif-quick (Fisher
Scientific, Houston, TX), then non-migrated cells were
manually removed from the upper membrane surface by
gentle friction with a cotton swab. Because migration can
be greater in the center than edges of wells, only the center
of each well was examined. The number of migrated Clara
cells was counted in one hpf, at the center of each well in
twelve individual wells per experiment. Results represent
the average number of cells migrated per hpf from at least
three independent experiments +/- SEM (at least 10 wells
per condition). In independent experiments, C22 cells
were incubated with GSRGD or GSRGE peptides for 5 min
at room temperature prior to addition of the cell/peptide
mixture to haptotaxis chambers. The GSRGD and GSRGE
peptides were a gift from Dr. R. Mecham (Washington
University, St. Louis, MO) and synthesized as described
[32].
Statistical analysis
The statistical significance of all results were evaluated by
performing an ANOVA test with a Scheffe posthoc analy-
sis to account for the multiple comparisons between con-
ditions or concentrations (SPSS 13, SPSS, Chicago, Il).
Results
Isolation of Mouse Clara Cells
Previous attempts to isolate mouse Clara cells have been
hampered by limited purity, cell quantity, or the availabil-
ity of an elutriator [23,24,33,34]. Using a modification of
a mouse type II cell isolation technique [28], we have
obtained an enriched Clara cell population. This tech-
nique does not require elutriation, and gives yields similar
to other published methods (Table 1). Clara cells have a
high level of NADPH oxidase activity that results in reduc-
tion of the soluble yellow NBT substrate to a purple for-
mazan precipitate. Immunohistochemistry for Clara cell
specific protein CC10 (Fig 1A,D,G) and NBT staining were
similar (see additional file 1), so NBT percentage was used
to determine the number of Clara cells for plating.
Although some ciliated cells and type II cells can stain
lightly with NBT, a short fixation with formalin clearly
separates the dark staining Clara cells from non-Clara cells
[35]. Our yield was approximately 2 × 105 Clara cells per
mouse with 60–70% NBT-positive. The number of Clara
cells may be an underestimate as the Clara cells tend to
clump [22], and we did not alter our counts to correct for
this. Greater than 95% of cells were viable by trypan blue
exclusion (data not shown).
Similar to prior publications of Clara cell isolation tech-
niques the primary contaminating cell type was ciliated
(~20–30%) (Fig. 1E, white arrows) [25,31]. Likely this is
due to the clumping of isolated cells that contain some cil-
iated cells still adherent to Clara cells. The numbers of
cells staining for β-tubulin (Fig. 1E) may be an underesti-
mate of total ciliated lineage cells as cilia become short-
ened and shed during isolation. However immediately
after isolation both the shed cilia and shortened cilia
could be seen in cytospin preparations (Fig. 1E). Staining
for the FoxJ1 protein, which is an intracellular marker for
ciliated lineage cells, was less abundant in these prepara-
tions (data not shown) so β-tubulin was used. Contami-
Table 1: Summary of Mouse Clara Cell Isolation Procedures
First Author Date Mouse Strain Elutriation Yield % Clara Protease Ref
Massey, TE 1987 CD1 + 2 × 105 55–65 protease I [23]
Oreffo, VI 1990 Cba + 5 × 106 55 trypsin [21]
Forkert, PG 1990 CD1 + 2 × 105 40 protease I [33]
Belinsky, SA 1995 A/J + ns 76 protease I [22]
Hynes, DE 1999 CD1 + ns 64 elastase [53]
McBride, S 2000 C57Bl/6 + ns 75 trypsin [35]
Walker, SR 1989 BDF1 - 4 × 106 88 elastase [25]
Chichester, CH 1991 Swiss - 2 × 106 72 elastase [34]
Corti, M 1996 C57Bl/6 - ns 75–80 dispase [28]
Boogaard, PJ 2000 CD1 - 1 × 106 60 trypsin [24]
Blundell, RA 2005 C3H - ns ns trypsin [19]
Atkinson, JJ 2007 Swiss - 2 × 105 63–80 trypsin
ns – not statedRespiratory Research 2008, 9:1 http://respiratory-research.com/content/9/1/1
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nation with pro-SP-C positive, alveolar type II cells was
10% (Fig. 1H, white arrows). Greater than 90% of the cells
were positive for epithelial cell specific cytokeratins (Fig.
1B) and staining for vimentin was similar to the control
mouse IgG (data not shown), indicating minimal con-
tamination with fibroblasts or non-epithelial cells.
Clara cells have been demonstrated to downregulate P450
enzymes and CC10 in less than 24 hours in culture [25],
but immunohistochemistry for CC10 in our studies con-
firmed ~60% of cells were CC10 positive after 24 hours in
culture, suggesting the adherent population is enriched
for Clara cells even though CC10 staining may underesti-
mate Clara cell numbers at this time point.
Mouse Clara Cells Demonstrate Differential Adhesion to 
Matrix Components
Adhesive interactions between cells and extracellular
matrix proteins are important in cellular migration and
proliferation. Therefore, we examined the effects of com-
ponents of the basement membrane (Lm 111, 332, 511
and Col IV) and provisional matrix (Fn, Col I) on the
adhesive properties of Clara cells. Results are expressed as
mean number of adherent cells per five hpfs less the
mean number of adherent cells on uncoated wells in the
same experiment (Net Cells/hpf +/- SEM) (Fig. 2A). Clara
cells preferentially adhered to Fn (73 +/- 21) and Col I
(46 +/- 11), but adhesion to Lm 332 (16 +/- 6), Col IV
(16 +/- 5), Lm 511 (7 +/- 3) and Lm 111 (6 +/- 7) was not
significantly above uncoated controls. These findings are
consistent with prior reports that Clara cell adhesion was
enhanced by Fn or Col I coating of substratum [31].
These data suggest that freshly isolated Clara cells prefer-
entially bind to components of the provisional matrix
(Fn, Col I) compared with basement membrane compo-
nents (Col IV and laminins).
Representative cytospin preparation of isolated cells Figure 1
Representative cytospin preparation of isolated cells. 
(A, D, G) CC10 positive airway Clara cells (green) with 
DAPI counterstain. The same preparations were simultane-
ously stained for either (B) epithelial cytokeratins, (E) β-
tubulin positive ciliated cells, (H) pro-SPC positive alveolar 
type II cells (all in red). The third panel in each series demon-
strates the DAPI nuclear counterstain alone (C,F,I). In panel 
A, the white arrowhead demonstrates a typical Clara cell, 
grey arrows indicate an example of a non-epithelial/non-
Clara cell and white arrows indicate examples non-Clara, 
epithelial cells. In D, E and F white arrows indicate the loca-
tion of 6 ciliated cells, and in G, H and I, white arrows indi-
cate the location of 2 type II cells in the panels. All images at 
200×.
Clara cell adhesion on matrix substrates Figure 2
Clara cell adhesion on matrix substrates. (A) Adhesion 
of Clara cells to fibronectin (Fn, black), type I collagen (Col I, 
light grey), laminin 332 (Lm 332, black stippled), type IV colla-
gen (Col IV, striped), laminin 511 (Lm 511, dark grey), lam-
inin 111 (Lm 111, white stippled) slides. (B) C22 adhesion to 
Fn, Lm 332, Col IV, Lm 511, Lm 111, Col I. Results are 
expressed as net number of adherent cells (cells on substrate 
– cells on uncoated for that experiment) per high power field 
+/- SEM from five independent experiments. p values for 
comparison with uncoated control. *p < 0.001, **p < 0.05Respiratory Research 2008, 9:1 http://respiratory-research.com/content/9/1/1
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To confirm these findings, C22 cells were removed from
plates with trypsin/EDTA to simulate conditions present
during isolation. Adhesion was allowed for only 30 min
and performed in the absence of serum (which was
required for the Clara cells). C22 cells preferentially
bound to Fn (84 +/- 29), similar to the Clara cells, but Lm
332 (30 +/- 13) demonstrated significant adhesive prop-
erties for the C22 cells while Col I (-5 +/- 4) was no more
adhesive than the uncoated controls (Fig. 2B). The differ-
ences between isolated Clara cells and the C22 cells may
represent effects of the isolation vs. the brief trypsiniza-
tion of the C22 cells or an intrinsic difference in matrix
adhesion receptor expression between the C22 cells and
the Clara cells. Similar to the Clara cells, the C22 cells
were slightly more adherent to Col IV (22 +/- 8) and Lm
511 (13 +/- 9) than Lm 111 (-1 +/- 2) (not statistically sig-
nificant from each other or uncoated). Although all are
basement membrane molecules, Lm 111 is not expressed
by the lung except during early embryonic development
[36].
Mouse Clara Cells Proliferate in vitro Independent of 
Matrix Substratum
Clara cells proliferate in response to airway epithelial
injury and are the progenitor cell of the small airway epi-
thelium [5,37,38]. Alterations in the extracellular matrix
during injury may regulate the Clara cell proliferative
response. To examine the effects of matrix substrates on
Clara cell proliferation, freshly isolated Clara cells were
plated on chamber slides that were precoated with matrix
proteins. After allowing cells to adhere for 18 hours, non-
adherent cells were removed and the remaining Clara cells
were incubated for 24 additional hours in the presence of
BrdU. Since there was differential adhesion of Clara cells
to matrix substrates (Fig. 2A), the number of cells incor-
porating BrdU was calculated as a percentage of the total
number of adherent cells. All conditions demonstrated
approximately 20–25% of cells incorporating BrdU (Fig.
3) without any significant difference between matrix sub-
strates. Thus, unlike adhesion, the matrix substratum had
no effect on the proliferative activity of our preparation of
Clara cells.
Clara Cells Demonstrate Differential Migration to Matrix 
Substrates
Since extracellular matrix molecules can direct migration
of both airway ciliated and alveolar type II epithelial cells
[12,14], the effects of matrix gradients on Clara cell migra-
tion were examined. Although all matrix components
examined had some chemokinetic activity, checkerboard
analyses revealed that none demonstrated significant
directional chemotaxis (data not shown). Therefore,
freshly isolated Clara cells were tested for haptotactic
migration in Boyden chambers with membranes coated
on the undersurface with matrix substrates for 24 hours.
The Clara cells migrated toward the adhesive gradient in
the substratum in all conditions (Fig. 4A). There was little
migration without a haptotactic gradient, so differences
were significant despite relatively small numbers of
migrated cells. The pro-migratory effect of the Fn hapto-
tactic gradient (16 +/- 1.3) was greater than that of the
other substrates (p < 0.03 compared to Col I, p < 0.01
compared with Lm 511) similar to the adhesive effects of
Fn on the Clara cells. Col I (9 +/- 0.8), which had the
capacity to promote Clara cell adhesion (Fig. 2A), also
increased haptotaxis over uncoated membranes. Lm 511
(5.6 +/- 0.7) demonstrated only a non-significant trend
toward increased haptotaxis over the uncoated control
membrane. Lm 111 and Col IV did not demonstrate any
significant haptotactic activity (data not shown).
Adhesion of Clara cells to membranes prepared for hapto-
taxis (coating of undersurface only) was also examined to
ensure migration effects were not due to adhesion differ-
ences. Although there is a more rapid adhesion and
spreading on Fn undercoated membranes, by 4 hours
there was no significant difference in the number of cells
adherent to the upper surface of membranes in any of the
conditions examined (data not shown).
To establish that the migratory cells were Clara cells and
not the contaminating ciliated or alveolar type II epithe-
lial cells, the cells on the underside of the membrane were
stained for CC10, epithelial pan-cytokeratin, β-tubulin
and SP-C. Nearly all of the migrated cells were positive for
Clara cell proliferation on matrix substrates Figure 3
Clara cell proliferation on matrix substrates. Adherent 
cells at 18 hours were treated with BrdU in 10% FCS con-
taining media for 24 hours. The percentage of cells incorpo-
rating BrdU over this time period on Fn, Col I, Lm 511, Col 
IV, Lm 332, Lm 111 or uncoated (Un, white) slides is shown. 
Results are expressed as mean percent of BrdU positive cells 
per high power field +/- SEM from three independent isola-
tion experiments. No conditions were statistically significant 
from uncoated wells.Respiratory Research 2008, 9:1 http://respiratory-research.com/content/9/1/1
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epithelial cytokeratins (90%) (Fig. 4B) and the majority
were CC10 expressing (50%) (Fig. 4C). Most β-tubulin is
shed when ciliated cells spread, and we found only rare
cells positive for β-tubulin (Fig. 4D) or SP-C (data not
shown). Thus the majority of migrated cells were Clara
cells. Likely the downregulation of CC10 production is
responsible for some of the decrease in percentage of
CC10 positive cells applied versus migrated, but the con-
tribution of dedifferentiated ciliated cells can not be
excluded.
C22 Cells Migrate like Clara Cells to Matrix Proteins
Our modified isolation procedure has provided a reliable
method for obtaining a relatively pure population of
Clara cells, but the yield is too low for some studies and
primary Clara cells still require serum for adhesion which
contains Fn. Since we can not generate completely pure
Clara cell preparations, we repeated the migration assays
with the C22 line to evaluate if they were a valid surrogate
for Clara cell migratory activities.
C22 cells were assayed at 8 and 16 hours because of the
greater migratory activity of this cell line compared with
Clara cells. Although the 8 hour data demonstrated signif-
icant migration towards Fn (Fig. 5A), the 16 hour time
point was utilized for subsequent experiments because
additional substrates demonstrated significant haptotac-
tic activity at this time point (Fig. 5B). Fn elicited the
greatest migratory response (128 +/- 3 migrated cells per
hpf at 16 hours, p < 0.001 compared with all substrates).
Lm 511 (99 +/- 3) and Col I (65 +/- 5) also demonstrated
significant haptotactic activity at 16 hours (significantly
different from each other p < 0.001 and control p <
0.001). Lm 111 was less pro-migratory (31 +/- 2, p <
0.001), but more efficient than Lm 332 (20 +/- 2, p =
0.002) and Col IV (15 +/- 1.5, p = 0.091) (all p values
listed for comparison with control and not significantly
different from each other). Differences seen in the total
number of migrated cells between the Clara (Fig. 4A) and
C22 cells (Fig. 5) likely represents enhanced adhesion of
C22 cells. In addition, the C22 cells did not require serum
in the upper chamber, which contains some Fn that will
alter the migratory gradient in the primary Clara cell
assays.
C22 Cell Migration Is Predominantly RGD 
Integrin-Dependent
Preincubation of C22 cells with integrin blocking
(GSRGD) and irrelevant (GSRGE) peptides was per-
formed to determine the mechanism of C22 cell interac-
tion with the matrix substrates. Increasing concentrations
of the RGD-containing peptide resulted in a dose-depend-
ant inhibition of C22 cell haptotaxis to Fn (118 +/- 7, 56
Clara cell haptotaxis toward matrix peptides Figure 4
Clara cell haptotaxis toward matrix peptides. (A) 
Migration to the lower membrane surface was measured per 
high power field to membranes undercoated with Fn, Col I, 
Lm 511 or uncoated control (Un, white) membranes. Results 
are expressed as mean number of cells per high power field 
+/- SEM from three independent isolations. p values for com-
parison with uncoated control. *p < 0.001, **p < 0.05. Rep-
resentative example of migrated cells on the undersurface of 
a Fn coated membrane stained for (B) epithelial cytokeratins 
(red) stain, (C) CC10 (green) and (D) β-tubulin (red) with 
DAPI nuclear counterstain.
C22 haptotaxis toward matrix peptides Figure 5
C22 haptotaxis toward matrix peptides. Migration to 
the lower membrane surface after 8 (A) and 16 hours (B) 
was measured to Fn, Lm 511, Col I, Col IV, Lm 332, Lm 111 
or uncoated control (Un). Results are expressed as mean 
number of cells per high power field +/- SEM from five inde-
pendent experiments. p values for comparison with uncoated 
control. *p < 0.001, **p < 0.05.Respiratory Research 2008, 9:1 http://respiratory-research.com/content/9/1/1
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+/- 6, 19 +/- 2) (Fig. 6) as compared to the absence of pep-
tide (128 +/- 3; Fig 5B). Haptotaxis to Lm 511 was also sig-
nificantly inhibited by the RGD containing-peptide (76 +/
- 4, 18 +/- 2, 10 +/- 2 vs. 99 +/- 3), but the haptotaxis to
Lm 511 did not demonstrate the same dose response as
was seen with Fn, indicating the migration to Lm 511 was
more sensitive to RGD dependent integrin blockade than
Fn. This is interesting because intact Lm 511 is not known
to interact with RGD specific integrins. However the min-
imally pepsin digested placental laminin (which is actu-
ally a mixture of Lm 511 and 521) used in this assay has
been described to have adhesive activity that is enhanced
with further pepsin digestion, suggesting a cryptic RGD
site, similar to that described in Lm 111, may be present
in this preparation [39].
Although there appeared to be a trend towards decreased
haptotaxis to Col I after treatment with the RGD peptide,
this was not significant due to a relatively high variation
in C22 haptotaxis to Col I (40 +/- 5, 38 +/- 7, 25 +/- 5 vs.
31 +/- 2).
Lm 332 (13.8 +/- 2, 9.4 +/- 1, 14.9 +/- 3), which is another
common component of airway epithelial basement mem-
brane, was less of a pro-migratory substrate for C22 cells
(20 +/- 2; Fig. 5), and demonstrated no significant inhibi-
tion of migration when pre-incubation with RGD was per-
formed (Fig. 6). The RGE-containing peptide did not alter
the migrational capacity of C22 cells to any matrix sub-
strate (No difference when compared with Fig. 5B).
Discussion
In this paper, we describe a reproducible procedure for
murine Clara cell isolation, evaluate Clara cell migration
to several matrix substrates relevant to wound repair, and
characterize the immortalized Clara-like cell line (C22),
as a possible surrogate for Clara cells in migration assays.
This work lays a foundation for future studies regarding
the Clara cell in injury models where migration from a
protected cell niche across matrix that may be altered after
injury is present. The role of the Clara cell in small airway
repair makes this information integral to our understand-
ing of lung injury and repair.
Our modified technique of mouse Clara cell isolation
provides relatively pure yields of Clara cells without the
need for elutriation, but Clara cell lines are needed to
study Clara cells because clumping of this population
with ciliated and/or type II cells results in an inability to
remove non-Clara cells without significantly decreasing
yields. All of the airway epithelial cell type specific mark-
ers are lost with time in cultures as the lung epithelial cells
de-differentiate. The inability to monitor airway epithelial
cell type in culture makes the Clara-like C22 cell line
essential to confirm our findings are not skewed by con-
taminating ciliated cells. Mature Clara cells can also be
developed in air-liquid interface cultures, but this method
produces mostly ciliated cells and is more representative
of a mouse trachea [40,41].
The preferential interaction of Clara cells to Fn and Col I
in vitro suggests that the provisional matrix seen in epithe-
lial injury plays an important role in promoting Clara cell
migration in vivo. Col I and Fn are not present in the epi-
thelial basement membrane, but can be major compo-
nents of the provisional matrix seen after injury [42].
Uninjured basement membranes of adult terminal airway
epithelial cells usually contain Lm 332 and Lm 511, as
well as Col IV [36,43-46]. It is known that degradation of
the matrix can reveal cryptic sites with pro-migratory
activity, so the pepsinized Lm 511 used in these experi-
ments may also represent an injured basement membrane
rather than a stable mature basement membrane [10,47].
The migratory effect of Lm 511 in C22 cells was signifi-
cantly RGD-dependent, suggesting that a previously
described cryptic RGD site is present in this preparation,
but not in Lm 332 or intact Lm 111 [39]. This is consistent
with the findings of others that the commercial prepara-
tion of Lm 511 contains activities that are not present in
intact basement membrane [48]. Of note the cryptic RGD
site of Lm 111 was found to bind β3 but not β1 integrins
in osteoclasts, suggesting that αvβ3 (the classic vitronectin
binding integrin) is involved [49]. However, consistent
C22 haptotaxis after pretreatment with integrin blocking  peptides Figure 6
C22 haptotaxis after pretreatment with integrin 
blocking peptides. C22 cells were pretreated with GSRGD 
peptide (100, 10 or 1 μM) or GSRGE peptide (100 μM), then 
the number of migrated cells at 16 hours was measured. 
Independent experiments were performed for Fn (black), Lm 
511 (dark grey), Col I (light grey) or Lm 332 (black speckled) 
undercoated membranes. Results are expressed as mean 
number of cells per high power field +/- SEM from three 
independent experiments. *p < 0.001 compared with DMEM 
control, #p < 0.05 compared with 10 μM dose.Respiratory Research 2008, 9:1 http://respiratory-research.com/content/9/1/1
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with published reports [19], we have been unable to
detect β3 integrin by immunohistochemistry in our Clara
or C22 cells (unpublished observations), suggesting an
integrin other than αvβ3 must be responsible for this
activity in C22 cells.
Although Lm 332 is the most abundant laminin in the air-
way basement membrane, C22 cells demonstrated less
haptotactic migration towards this substrate than others.
It is well known that processing of both the α3 and γ2
chains of the Lm 332 trimer results in enucleation of the
stationary hemidesmosomes or pro-migratory activity,
respectively [10]. The Lm 332 preparation that we used
should contain predominantly trimers with α3 in an anti-
migratory, pro-hemidesmosomal state so the lack of pro-
migratory activity of our Lm 332 preparation when com-
pared with pepsinized Lm 511 is not unexpected.
Our use of 804 G conditioned media as a source of Lm
332 is similar to other studies [50], but the concentration
of Lm 332 on the membrane is unknown and could be
different than the other matrix substrates in this study.
Since 804 G cells are tumour cells and express some Fn
caution should be used in interpretation of the role of Lm
332 in C22 migration. However, since RGD did not block
the Lm 332 pro-migratory activity, contaminating Fn was
not the only source of promigratory effects in our assay.
The repair of isolated and in vitro differentiated bronchi-
olar epithelial cells requires integrin switching during
migration over the provisional matrix [18]. The switch
predominantly favours provisional matrix (Fn and/or
vitronectin) binding integrins (α5 and αv), over the colla-
gen and laminin binding integrins (α2 and α3) that tend
to be present in uninjured epithelial cells [18]. Mouse
Clara cells produce both α5 and αv integrins, both in vivo
and in vitro after isolation [19]. Our data demonstrates
that Fn and likely the RGD binding α5β1 and/or αv-con-
taining integrins play a role in Clara cell migration. These
results are consistent with the published data on both
alveolar type II and bronchiolar ciliated epithelial cells
[9,12,14]. Although both adhesion and migration was
greatest to Fn, not all of the matrix substances had the
same effect on adhesion and haptotactic migration. The
lack of significant C22 adhesion to Col I or Lm 511, but
enhanced migration to these substrates, suggests that
C22 cells have receptors (likely integrin) that detect Col
I and Lm 511, but signalling for adhesion and migratory
responses differ.
Inhibition of C22 haptotaxis to Lm 511 by RGD was sig-
nificant, consistent with a cryptic RGD site being present
in this preparation of Lm 511 but not in intact Lm 111
[49]. As would be expected, inhibition of haptotaxis to
Col I was not significantly altered by the RGD peptide.
However Col I assays had the greatest variability, and a
non-significant trend for RGD activity was present in C22
haptotaxis assays. The variability of the C22 cell line
response to Col I was unrelated to passage number or con-
fluence state prior to experiments. True inhibition of C22
haptotaxis to Col I with the RGD peptide would be unex-
pected, as collagen and laminin binding integrins (α2 and
α3) are not RGD specific, but there could be some binding
of RGD peptides to these integrins at the highest concen-
trations used in these experiments.
We utilized RGD activity in the absence of RGE activity to
confirm some of our results are integrin dependent, but
specific integrin interactions will require blocking anti-
bodies to different integrin chains. Integrin blocking anti-
bodies have been developed for human integrins, but the
efficacy of these antibodies on mouse integrins will need
to be established before further claims regarding the spe-
cific integrin matrix interaction in mouse Clara cells.
Unfortunately human Clara cells are less abundant and
could not be evaluated.
The provisional matrix should be a strong stimulus for
airway epithelial cell migration and there has been a con-
sistent effect of matrix substratum in both bronchiolar
epithelial cells and alveolar epithelial cells, so the
response of Clara cells is not surprising. It is known that
bronchiolar epithelial cell migration to Fn is enhanced by
exogenous epidermal growth factor (EGF) or insulin, and
inhibited by toxic insults like smoke extract [14,51]. Pre-
liminary results indicate that Clara cell haptotaxis to Fn
is not affected by EGF stimulation (data not shown).
Clara cells make EGF receptors as the development of
mucus metaplasia in Clara-like cells requires EGF medi-
ated signalling [52], but the role of EGF receptor signal-
ling in Clara cells may differ from that seen in ciliated
cells which demonstrate an EGF dependent increase in
haptotaxis.
Of note, matrix type did not alter the rate of proliferation
of primary Clara cells as long as adhesion was present.
Similar to mouse bronchiolar epithelial cells and unlike
mouse type II cells, significant proliferation of Clara cells
occurs in culture [28,40]. It is our experience that prolifer-
ation of Clara cells occurs even in low serum conditions
without exogenous growth factors, a characteristic not
typical of ciliated cells [40]. As mentioned previously, the
Clara cells are the small airway epithelial stem cell with
the ability to differentiate into both Clara and ciliated
cells and therefore may be more capable of proliferation
ex vivo.
C22 cells are the only murine cell line that synthesizes all
three surfactant proteins known to be products of Clara
cells (A, B, and D, but not C) as well as CC10 [27]. InRespiratory Research 2008, 9:1 http://respiratory-research.com/content/9/1/1
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addition C22 cells will develop contact inhibition, form
epithelial tight junctions, and a transepithelial resistance
of 196–368 Ω*cm2 when plated on Col IV coated mem-
branes [27]. After we determined C22 cells are similar to
Clara cells in haptotactic migration we utilized C22 cells
to study the role of integrins in matrix modulation of
Clara cell migration. Based on our preliminary studies,
these cells provide a useful reagent, as they appear to act
similar to primary Clara cells in our assays of migration.
Future evaluations utilizing C22 cells should increase our
knowledge of the Clara cell in small airway specific
repair.
Conclusion
In summary Clara cells can be isolated at relatively pure
yields from mice without the need for an elutriator. Simi-
lar to the neighboring ciliated and type II cells, Clara cells
migrate preferentially towards matrix molecules in the
absence of a growth factor gradient. The provisional
matrix provides adhesion and migration specific signals
for Clara cells, but does not alter the proliferative
responses. C22 cells are a valuable surrogate for primary
Clara cells in migration assays, and should be useful in
future studies of the response of Clara cells to injury.
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